Which breast cancer decisions remain non-compliant with guidelines despite the use of computerised decision support?

Abstract

Residual non-compliance despite the use of OncoDoc2 illustrates the need to question the clinical profiles where evidence is missing. These findings challenge the weaknesses of guideline content rather than the use of CDSSs.